These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1020 related articles for article (PubMed ID: 12942032)
1. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry. Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032 [TBL] [Abstract][Full Text] [Related]
2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients. D'Arena G; Cascavilla N; Musto P; Greco M; Di Mauro L; Carella AM; Dello Iacono N; Carotenuto M Haematologica; 1996; 81(3):216-23. PubMed ID: 8767526 [TBL] [Abstract][Full Text] [Related]
6. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment. Kusenda J; Babusíková O Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418 [TBL] [Abstract][Full Text] [Related]
7. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire]. Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262 [TBL] [Abstract][Full Text] [Related]
8. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229 [TBL] [Abstract][Full Text] [Related]
9. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease. Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155 [TBL] [Abstract][Full Text] [Related]
10. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy. Wongprajun S; Auewarakul CU J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S157-64. PubMed ID: 20364570 [TBL] [Abstract][Full Text] [Related]
11. A case of HLA-DR negative B-precursor acute lymphoblastic leukemia. Giotopoulou S; Dokou E; Tzoufi M; Kolaitis N; Vartholomatos G J Exp Clin Cancer Res; 2003 Dec; 22(4):637-40. PubMed ID: 15053308 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia]. Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262 [TBL] [Abstract][Full Text] [Related]
13. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia]. Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276 [TBL] [Abstract][Full Text] [Related]
14. Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias. Kern W; Kohlmann A; Schoch C; Schnittger S; Haferlach T Cancer; 2006 Nov; 107(10):2401-7. PubMed ID: 17041886 [TBL] [Abstract][Full Text] [Related]
15. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL. Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335 [TBL] [Abstract][Full Text] [Related]
16. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Janossy G; Coustan-Smith E; Campana D Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463 [TBL] [Abstract][Full Text] [Related]
17. DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis. Inokuchi K; Miyake K; Takahashi H; Dan K; Nomura T J Clin Invest; 1996 Feb; 97(3):852-7. PubMed ID: 8609244 [TBL] [Abstract][Full Text] [Related]
18. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis. Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic quantitative features of patients with acute myeloid leukemia. Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]